Boehringer Ingelheim appoints Meenal Gauri as Managing Director for India region

INDIA—Boehringer Ingelheim has appointed Meenal Gauri as Managing Director India, with her tenure beginning on 12 January 2026.

She will oversee the pharmaceutical company’s operations across India, Bangladesh, Nepal, Sri Lanka, and Maldives while joining the Board of Boehringer Ingelheim India.

Extensive international experience

Gauri brings over 16 years of international healthcare experience spanning Europe, Asia, and the Middle East.

Her professional expertise encompasses marketing, sales, corporate strategy, business development, and market access.

This diverse background has equipped her with a comprehensive understanding of healthcare ecosystems across multiple geographies, positioning her to lead Boehringer Ingelheim India toward its ambitious India Vision 2030 goals.

Track record of success

Throughout her tenure in regional roles at Boehringer Ingelheim, Gauri has strengthened the company’s presence across complex markets.

She has successfully led high-impact product launches and developed strategic initiatives that expanded the organization’s reach.

Beyond her business acumen, Gauri holds credentials as a trained Co-Active coach, demonstrating her commitment to developing future leaders.

This focus on talent development aligns closely with Boehringer Ingelheim’s culture of collaboration and long-term commitment to its workforce.

Looking ahead

Reflecting on her new role, Gauri described her journey at Boehringer Ingelheim as both inspiring and purposeful.

She acknowledged that since joining the company, she has experienced significant professional growth through diverse interactions with exceptional colleagues across different regions and the broader healthcare community.

Gauri emphasized that India remains a fascinating and dynamic market, expressing her deep commitment to improving patient health throughout the country.

She stated her eagerness to collaborate with teams and partners to deliver impactful innovations that make a meaningful difference in people’s lives.

Leadership endorsement

Evren Ozlu, Head of Human Pharma for India, Middle East, Turkey, and Africa (IMETA), praised the appointment.

He highlighted that Gauri brings profound industry expertise combined with a people-first approach that reflects the company’s core values.

Ozlu expressed confidence that under her leadership, the India business will advance innovation, strengthen partnerships, and have a positive impact on patients and communities across the region.

Personal perspective

Outside her professional responsibilities, Gauri is an avid traveller and the mother of two children.

She holds a firm belief in continuous learning and personal development, values that shape both her leadership approach and her approach to nurturing others within the organisation.